Rewarding Healthy Behaviors in Pregnancy and Postpartum
1 other identifier
interventional
27
1 country
1
Brief Summary
This is a single-arm pilot clinical trial with two primary research goals:
- 1.To test the efficacy of a software's ability to profile eligible individuals who decline participation in a clinical trial ("non-consenters") so that research staff may improve recruitment strategies for subsequent waves of potential participants.
- 2.To test the feasibility of using the software's contingency management program in a population of pregnant persons in their third trimester of pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2022
CompletedFirst Posted
Study publicly available on registry
April 14, 2022
CompletedStudy Start
First participant enrolled
July 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 8, 2023
CompletedJanuary 2, 2024
December 1, 2023
10 months
March 24, 2022
December 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Percentage of prenatal appointments attended
Using data from Mt. Sinai's electronic medical record appointment tracking system, the investigators will determine whether participants who received the Aqueduct system intervention demonstrate increased attendance at scheduled prenatal visits compared with baseline data in the clinic about attendance rates.
4 months
Percentage of postpartum appointments attended
Using data from Mt. Sinai's electronic medical record appointment tracking system, the investigators will determine whether participants who received the Aqueduct system intervention demonstrate increased attendance at scheduled postpartum visits compared with baseline data in the clinic about attendance rates.
4 months
Percentage of eligible target population who consent to participate
Using descriptive statistics from recruitment, the investigators will determine whether the percentage (%) of eligible individuals from the population of pregnant women in their third trimester receiving prenatal care at the Mt. Sinai E-Level OB Clinic who elected to participate in the study increases between Wave 1 and Wave 2 of recruitment based upon changes in recruitment language.
4 months
Secondary Outcomes (3)
Changes in healthy eating between baseline and follow-up
4 months
Changes in exercise habits between baseline and follow-up
4 months
Changes in self-efficacy between baseline and follow-up
4 months
Study Arms (1)
Adherence Incentives Program
EXPERIMENTALThe intervention administered to participants is an incentive program designed to motivate participants to attend to/adhere to their prescribed prenatal course of care via the Aqueduct platform.
Interventions
All individuals who consent to participate will engage with the Aqueduct contingency management system. Once participants are enrolled, they accumulate points in Aqueduct for each prenatal/postpartum appointment they attend. They also earn points for attending pregnancy and birth related classes, monitoring their health (e.g., blood sugar, blood pressure), and taking prescribed medications. Participants then redeem their points for money on a Visa gift card. Enrolled participants also receive daily text messages that contain motivational and mini-educational content regarding pregnancy from trusted sources such as the American College of Obstetricians and Gynecologists, Evidence Based Birth, and Postpartum Support International. These texts serve as reminders to participants to remain engaged in their pregnancy care.
Eligibility Criteria
You may qualify if:
- Pregnant in third trimester of pregnancy
- Between 18 and 52 years of age
- Able to read and speak either English or Spanish
- A patient at Mount Sinai Hospital's OB-Gyn Ambulatory E-Level Clinic
You may not qualify if:
- Not pregnant (or no longer pregnant)
- Outside of age range
- Unwilling or unable to complete surveys
- Not a patient at the clinic of interest
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Transcendent International, LLClead
- MOUNT SINAI HOSPITALcollaborator
Study Sites (1)
Mount Sinai Hospital OB-Gyn Clinic E-Level
New York, New York, 10029, United States
Study Officials
- STUDY DIRECTOR
Aviva H Ariel-Donges, PhD, MPH
Transcendent Endeavors
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2022
First Posted
April 14, 2022
Study Start
July 12, 2022
Primary Completion
May 8, 2023
Study Completion
May 8, 2023
Last Updated
January 2, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share